HeartCore Enterprises, Inc. (HTCR) - 10-Q Summary for Period Ended September 30, 2025
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended September 30, 2025. HeartCore Enterprises, Inc. is a holding company primarily engaged in software development and consulting services, specifically supporting Japanese companies in their U.S. IPO processes ("GO IPO" business). The Company is classified as a non-accelerated filer, smaller reporting company, and emerging growth company. A significant strategic shift occurred during the period: the Company classified its Japanese software subsidiary, HeartCore Japan, as discontinued operations following a decision to sell the entity, a transaction that closed on October 31, 2025.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 2025 | Nine Months Ended Sept 30, 2025 | Three Months Ended Sept 30, 2024 | Nine Months Ended Sept 30, 2024 |
|---|---|---|---|---|
| Revenues (Continuing Ops) | $2,990,329 | $7,052,799 | $16,240,865 | $21,270,891 |
| Gross Profit | $1,468,409 | $2,599,064 | $14,010,116 | $15,062,006 |
| Gross Margin | 49.1% | 36.9% | 86.2% | 70.8% |
| Net Income (Loss) from Continuing Ops | $(137,122) | $(2,913,181) | $11,119,592 | $6,705,342 |
| Net Income (Loss) from Discontinued Ops | $488,297 | $1,188,481 | $(302,662) | $422,468 |
| Net Income (Loss) Attributable to Common Shareholders | $377,850 | $(1,609,851) | $11,057,806 | $7,773,356 |
| Cash and Cash Equivalents (Sept 30, 2025) | $1,451,019 | |||
| Total Debt (Current + Non-Current) | ~$581,812 (Excluding discontinued ops) |
Material Changes vs. Prior Period
- Revenue Decline: Revenues from continuing operations decreased 81.6% quarter-over-quarter and 66.8% year-to-date. This is primarily due to a lack of large non-cash consideration revenue from IPO consulting deals in 2025 compared to 2024, and a slowdown in the U.S. software market.
- Profitability Shift: The Company swung from a net income of $11.1 million in Q3 2024 to a net loss from continuing operations of $137,122 in Q3 2025. Gross margins compressed significantly from 86.2% to 49.1% due to the absence of high-margin non-cash revenue recognition.
- Discontinued Operations: Results from HeartCore Japan are now reported as discontinued operations. This segment contributed a net income of $488,297 in Q3 2025, offsetting the loss from continuing operations.
- Equity Transactions: In June 2025, the Company issued Series A convertible preferred shares and common shares, raising net proceeds of $1.8 million. Subsequent events in October 2025 included the conversion of preferred shares into common stock.
Outlook, Risks, and Unusual Items
- Strategic Pivot: Management is concentrating efforts on the GO IPO consulting business following the sale of HeartCore Japan (closed Oct 31, 2025, for approx. $12 million).
- Nasdaq Compliance: The Company received notice of non-compliance with the $1.00 minimum bid price requirement. It was granted an additional 180-day period (until May 1, 2026) to regain compliance, potentially via a reverse stock split.
- One-Time Distribution: A special distribution of $0.13 per share ($3.2 million total) was declared and paid in November 2025.
- Controls and Procedures: Management concluded that disclosure controls and procedures were not effective as of September 30, 2025, citing reasons previously disclosed in the 2024 10-K.
- Unusual Items: Significant volatility in "Other Income/Expenses" due to fair value changes in warrant investments and marketable securities. In Q3 2024, a $3.97 million loss on the sale of warrants occurred, which did not repeat in 2025.
Investor Verification Checklist
- Discontinued Operations Sale: Verify the final purchase price and any holdback adjustments for the HeartCore Japan sale to Smith Japan Holdings KK.
- Nasdaq Listing Status: Monitor the stock price to ensure compliance with the $1.00 minimum bid price requirement by May 1, 2026, to avoid delisting.
- Revenue Quality: Assess the sustainability of the GO IPO consulting revenue model, which relies heavily on non-cash consideration (warrants/stock) that is subject to fair value volatility and IPO completion timing.
- Liquidity Position: Review the impact of the $3.2 million special distribution on remaining cash reserves ($1.45 million) and the ability to fund operations without further equity raises.
- Internal Controls: Investigate the specific material weaknesses in internal controls that led to the ineffective disclosure controls conclusion.